Repurposing drugs as inhaled therapies in asthma

@article{Anderson2018RepurposingDA,
  title={Repurposing drugs as inhaled therapies in asthma},
  author={S. Anderson},
  journal={Advanced Drug Delivery Reviews},
  year={2018},
  volume={133},
  pages={19–33}
}
  • S. Anderson
  • Published 2018
  • Medicine
  • Advanced Drug Delivery Reviews
&NA; For the first 40 years of the 20th century treatment for asthma occurred in response to an asthma attack. The treatments were given by injection or orally and included the adrenergic agonists adrenalin/epinephrine and ephedrine and a phosphodiesterase inhibitor theophylline. Epinephrine became available as an aerosol in 1930. After 1945, isoprenaline, a non‐selective beta agonist, became available for oral use but it was most widely used by inhalation. Isoprenaline was short‐acting with… Expand
Differential effects of inhaled R- and S-terbutaline in ovalbumin-induced asthmatic mice.
Future Trends in Nebulized Therapies for Pulmonary Disease
Design of New Polyaspartamide Copolymers for siRNA Delivery in Antiasthmatic Therapy
Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents
...
1
2
...

References

SHOWING 1-10 OF 274 REFERENCES
Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
  • B. Lipworth, M. Kaliner, +7 authors D. Banerji
  • Medicine
  • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2005
Salmeterol: a novel drug for the treatment of asthma.
  • M. Johnson
  • Medicine
  • Agents and actions. Supplements
  • 1991
Soft steroids: a new approach to the treatment of inflammatory airways diseases.
...
1
2
3
4
5
...